Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of immunotherapy products, today announced a research to conduct preclinical studies in collaboration and agreement with the University of California Los Angeles (UCLA) in evaluating the Company’s Lm technology i....
Tags : Biotech research, find a cure, cancer, Biotech , diseases ,
comments (0)